Evidence map›Paper›PMID 40608399›Full record

ReviewAnalytical chemistry2025

A Large Language Model-Powered Map of Metabolomics Research.

Olatomiwa O Bifarin, Varun S Yelluru, Aditya Simhadri, Facundo M Fernández

Abstract readReview
In one paragraph

Review in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Olatomiwa O BifarinSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-5379-0881
Varun S YelluruSchool of Computer Science, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Aditya SimhadriSchool of Computer Science, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Facundo M FernándezSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.

Funding

Deep Ovarian Cancer MetabolomicsR01CA218664 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Facundo Martin Fernandez, Jaeyeon Kim · 2018 to 2026
$4.3M
Population-Based Characterization of Metabolic Pathways to Predict Pediatric Crohn's Disease OutcomesR01DK132369 · NIDDK · UNIVERSITY OF VIRGINIA · PI Sana Syed · 2022 to 2026
$3.4M
Integrative multi-omic risk assessment at diagnosis and during disease progression in African-Americans with Inflammatory bowel diseaseU01DK134191 · NIDDK · EMORY UNIVERSITY · PI SUBRA KUGATHASAN · 2022 to 2026
$2.8M
Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell CarcinomasR61CA281667 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI FERNANDEZ, FACUNDO MARTIN · 2023 to 2025
$606k
NCI NIH HHS R01 CA218664NCI NIH HHS R61 CA281667NIDDK NIH HHS R01 DK132369NIDDK NIH HHS U01 DK134191
6 · The paper itself

Abstract

We present a comprehensive map of the metabolomics research landscape, synthesizing insights from over 80,000 publications. Using PubMedBERT, we transformed abstracts into 768-dimensional embeddings that capture the nuanced thematic structure of the field. Dimensionality reduction with t-SNE revealed distinct clusters corresponding to key domains, such as analytical chemistry, plant biology, pharmacology, and clinical diagnostics. In addition, a neural topic modeling pipeline refined with GPT-4o mini reclassified the corpus into 20 distinct topics─ranging from "Plant Stress Response Mechanisms" and "NMR Spectroscopy Innovations" to "COVID-19 Metabolomic and Immune Responses." Temporal analyses further highlight trends including the rise of deep learning methods post-2015 and a continued focus on biomarker discovery. Integration of metadata such as publication statistics and sample sizes provides additional context to these evolving research dynamics. An interactive web application (https://metascape.streamlit.app/) enables the dynamic exploration of these insights. Overall, this study offers a robust framework for literature synthesis that empowers researchers, clinicians, and policymakers to identify emerging research trajectories and address critical challenges in metabolomics while also sharing our perspectives on key trends shaping the field.

Indexed as

MetabolomicsBiomarkersCOVID-19HumansLarge Language ModelsSARS-CoV-2Biomarkers

Identifiers

PMID40608399
PMCPMC12268820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.